Pharmaceutical Business review

Cayenne secures $15 million in series C financing

Other participating investors include SplitRock Partners, MB Venture Partners and a group of accredited private individuals. Stephen Campe, managing director of IGC, has joined Cayenne’s board in connection with the financing. This financing round brings Cayenne’s total private equity investment to $32 million.

James Hart, president and CEO of Cayenne, said: “This successful round of financing will enable us to expand our sales and distribution footprint and further support the continued roll-out of our AperFix System. In addition, we remain committed to serving our growing physician customer base by developing and commercializing a full line of sports medicine products.”